A Critical Update on Therapy Selection, Sequencing, and Toxicity Management of Novel Therapies for Multiple Myeloma

To participate in this activity, please:

In this program, Sagar Lonial, MD, a nationally recognized expert in multiple myeloma, guides participants through a series of clinical questions centered around four patient cases. These cases serve as a framework for exploring risk stratification, treatment selection, and adverse effect management in patients with multiple myeloma. Faculty member, Dr. Lonial, provides responses to these clinical questions, offering valuable insights and evidence-based recommendations. Dr. Lonial's extensive research and clinical experience in the field enable him to share best practices and clinical pearls for managing relapsed/refractory multiple myeloma in adults. The program format fosters interactive discussions, allowing participants to engage with the patient cases and benefit from the expertise of the faculty.

Course Credit:

1 AMA PRA Category 1 CreditTM
1 ANCC Contact Hour
1 Pharmacology Hour


Opens: 2023-05-25
Closes: 2024-05-25

Target Audience:

This activity is intended for hematologist-oncologists, advanced practitioners, oncology nurses, pharmacists, and other healthcare professionals involved in the care of patients diagnosed with multiple myeloma.

This activity is supported by educational grants from Sanofi and Karyopharm.

    Presenting Faculty

  • Sagar Lonial, MD, FACP

    Chair and Professor
    Department of Hematology and Medical Oncology
    Anne and Bernard Gray Family Chair in Cancer
    Chief Medical Officer
    Winship Cancer Institute
    Emory University School of Medicine
    Atlanta, Georgia